HEG (HEG)
CyclicalFairStock Score: 61/100 — STEADY
Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹701 |
| Market Cap | ₹13,527.73 Cr |
| P/E Ratio | 37.59 |
| ROCE | 3.96% |
| ROE | 8.56% |
| Dividend Yield | 0.49% |
| Profit Growth | 52.51% |
| Debt/Equity | 0.17 |
| Sales Growth | 10.67% |
| Free Cash Flow | ₹72.86 Cr |
| Promoter Holding | 56.13% |
| 52-Week Range | ₹237.65 — ₹753.9 |
| Sector | Industrial Products |
| Book Value | ₹246.55 |
Strengths
- Low leverage: Debt/Equity 0.13 with Piotroski F-Score 8/9 indicates sound near-term financial health.
- Promoter holding of 56.13% aligns management with minority shareholders.
- Latest quarter momentum: Sales ₹656 Cr and Net Profit ₹207 Cr, with sales growth of 16.19% and profit growth of 72.12%.
- Altman Z-Score of 2.58 suggests no imminent bankruptcy risk.
Concerns
- Valuation appears rich: P/E 29.23, P/B 2.90, EV/EBITDA 107.13, while Graham Number ₹320.33 and DCF Value ₹202.12 are far below market price ₹668.40.
- Return on capital is weak: ROE 8.56% and ROCE 3.96%, suggesting limited economic moat and cyclical pressure.
- Free cash flow of ₹73 Cr is much lower than the latest quarter profit of ₹207 Cr, raising profit-quality/cash conversion questions.
- Graphite electrodes are inherently cyclical; current high profit growth may reverse when electrode prices and steel demand cycle down.
AI Analysis
At ₹668 a share, HEG has certainly caught Mr. Market's eye. But I am not here to be entertained; I am here to own businesses at a price below intrinsic worth. The numbers before me are contradictory. On one hand, the latest quarter shows a net profit of ₹207 Cr on sales of ₹656 Cr, and profit growth of 72.12% looks impressive. The low debt/equity of 0.13 and a Piotroski F-Score of 8/9 tell me the balance sheet has been managed conservatively, and promoter holding of 56.13% is a good sign. But that is where my enthusiasm ends. This is a cyclical graphite electrode business, not a resilient franchise. Trailing ROE is only 8.56% and ROCE is just 3.96%; those are not numbers of a company with a wide economic moat. If I annualise the latest quarter profit, the market looks cheaper, but that is exactly the trap in cyclicals—today's peak earnings feel permanent, yet prices and margins revert. The trailing P/E of 29.23 and, more alarmingly, an EV/EBITDA of 107.13 suggest either EBITDA has temporarily collapsed or the market is paying for a future that the current financials cannot justify. Both Graham Number of ₹320.33 and DCF value of ₹202.12 sit far below the market price of ₹668.40. The margin of safety is negative. I also notice free cash flow is only ₹73 Cr, far below the reported profit. Profits without cash are suspect in a cyclical downcycle. This is a financially solid company, but a poor price today. I will wait for a Mr. Market slump to offer real margin of safety. Patience is part of the process.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer